Wastage from Oversupply and Expired Lots
Definition
Poor tracking of lot expiry and stock levels results in oversupply, expiry, and direct financial wastage in medicines handling.
Key Findings
- Financial Impact: 2-5% of inventory value annually (AUD 20,000-100,000 for mid-size wholesaler)
- Frequency: Ongoing, peaks at lot expiry
- Root Cause: Manual Lot Number expiry monitoring
Why This Matters
The Pitch: Australian pharma wholesalers discard AUD 50,000+ annually in expired drugs due to lot tracking gaps. Automated NDC inventory rotation eliminates this loss.
Affected Stakeholders
Supply Chain Manager, Procurement
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Minimum Stockholding Requirement Breaches
S4R and S8 Medicines Inventory Discrepancies
Chargeback Fraud Claims
Chargeback Processing Errors
Manual Chargeback Reconciliation
PBS Wholesaler Supply Penalties
Request Deep Analysis
🇦🇺 Be first to access this market's intelligence